The current pregnant women living with hiv antiretroviral therapy coverage for pmtct of Egypt is 27%, this remains unchanged from 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Egypt
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Egypt
PMTCT antiretroviral therapy coverage
More indicators for Egypt
Male unintentional poisoning
0.2
0.0
(2019)
Female wasting in children
9.5%
+2.4%
(2014)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar338
+intl dollar27
(2021)
Birth registration
99.4%
+0.4%
(2014)
Contraceptive modern method prevalence
56.9%
-0.7%
(2014)
Egypt PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 27% | 0% |
| 2021 | 27% | +11% |
| 2020 | 16% | +2% |
| 2019 | 14% | +1% |
| 2018 | 13% | +1% |
| 2017 | 12% | 0% |
| 2016 | 12% | +4% |
| 2015 | 8% | 0% |
| 2014 | 8% | -3% |
| 2013 | 11% | +8% |
| 2012 | 3% | +1% |
| 2011 | 2% | -2% |
| 2010 | 4% | +1% |
| 2009 | 3% | +2% |
| 2008 | 1% | 0% |
| 2007 | 1% | -2% |
| 2006 | 3% | 0% |
| 2005 | 3% | +1% |
| 2004 | 2% | +2% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |